Qsymia: Data Find No Long-Term Heart Risk (CME/CE)

PHOENIX (MedPage Today) -- The more weight patients lost after 2 years on the diet drug Qsymia (phentermine/topiramate), the greater their improvements in cardiovascular risk markers, researchers reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news